Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2001
11/14/2001CN1322213A Treatment of inflammatory disease
11/14/2001CN1322146A Blood processing procedures with related sensing procedures
11/14/2001CN1321890A Nucteic acid amplification gene chip hybridization detecting instrument
11/14/2001CN1074836C Medical immunoassay device
11/14/2001CA2316169A1 Methods for analyzing boron-containing alkaline pulping liquors
11/13/2001US6317702 Method for instrument determination of a measured variable which changes with time
11/13/2001US6317696 Apparatus and method for detecting fluids
11/13/2001US6317511 Method and apparatus for particle image analysis using flow cell
11/13/2001US6317509 Computed tomography apparatus and method for classifying objects
11/13/2001US6316626 Amine compounds and combinatorial libraries comprising same
11/13/2001US6316611 Human N-methyl-D-aspartate receptor subunits, nucleic acids encoding same and uses therefor
11/13/2001US6316609 Nucleotide sequence of Escherichia coli pathogenicity islands
11/13/2001US6316608 Polynucleotides; for use in dection and measurement of preferential particles in sample
11/13/2001US6316607 Electrochemiluminescent assays
11/13/2001US6316603 Modifications of the VEGF receptor-2 protein and methods of use
11/13/2001US6316599 Preferential antibody for use in the diagnosis and detection and treatment of tumors
11/13/2001US6316416 Uteroglobin therapy for epithelial cell cancer
11/13/2001US6316409 Modified ligands of calcium-dependent binding proteins
11/13/2001US6316408 Methods of use for osetoprotegerin binding protein receptors
11/13/2001US6316404 Treatment of non-insulin-dependent diabetes mellitus using an rxr agonist alone or in combination with a ppar.gamma. agonist such as a thiazolidinedione compound.
11/13/2001US6316274 Device for accurate monitoring of preferential particles in sample
11/13/2001US6316273 Apparatus for monitoring preferential particles in solution
11/13/2001US6316272 Monitoring binding of cancer modulator; mix protein and modulator, incubate, detect binding of modulator
11/13/2001US6316269 Methods for screening drugs to predict tardive dyskinesia
11/13/2001US6316268 Chemical microsensors for detection of explosives and chemical warfare agents
11/13/2001US6316267 Combining sample mixture containingpoly(amino acid) with a staining mixture that contains one or more metal complexes; incubating combined mixture; illuminating said dye-poly(amino acid) complex; observing detectable optical response
11/13/2001US6316266 Sample presentation apparatus for mass spectrometry
11/13/2001US6316265 Determination of % glycated hemoglobin
11/13/2001US6316264 Dry phase test strip that ensures proper alignment of the test strip in detection apparatus, such as spectrophotometer; medical diagnosis
11/13/2001US6316263 Method for measuring antioxidant activities of samples and method for diagnosing diabetes or hyperlipidemia using the same
11/13/2001US6316254 Methods for stimulating erythropoiesis using hematopoietic proteins
11/13/2001US6316250 Molecular clones producing recombinant DNA antigens of the hantavirus-associated respiratory distress (HARDS)
11/13/2001US6316239 HKABY60 kinase family polypeptides
11/13/2001US6316230 Polymerase extension at 3′ terminus of PNA-DNA chimera
11/13/2001US6316227 Dna sequence encoding a composite heavy chain of a recombinant antibody molecule that specifically binds human interleukin-5 antigen
11/13/2001US6316222 Binds calcium-signal modulating cyclophilin ligand; use in identifying agents for modulating the calcium induced activation pathway
11/13/2001US6316219 Compounds
11/13/2001US6316215 Methods of cancer screening utilizing fluorescence detection techniques and selectable imager charge integration periods
11/13/2001US6316213 Methods for the early diagnosis of ovarian, breast and lung cancer
11/13/2001US6316209 Methods for diabetes susceptibility assessment in asymptomatic patients
11/13/2001US6316208 Methods for determining isolated p27 protein levels and uses thereof
11/13/2001US6316205 Assay devices and methods of analyte detection
11/13/2001US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001US6316200 Monitoring target nucleotide sequences; generate adaptor nucleotide sequences, hybridize reporter molecules to nucleotide sequences, detect hybridization products
11/13/2001US6316197 Monitoring exposure poisons; obtain mammalian body fluid, detect gene expression pattern, comparing pattern to control, evaluate if sample has been exposed to poisons
11/13/2001US6316190 Oligonucleotides which specifically bind retroviral nucleocapsid proteins
11/13/2001US6316186 Determining concentration of particles in sample; incubate sample with binding agent, incubate sample with solid support, determine concentration of preferential particle in sample by monitoring binding
11/13/2001US6316185 Quantitation of viruses by light scattering
11/13/2001US6316184 Diagnosing cancer in animals; obtain animal body fluid, determine the sequnce of preferential protein in sample, the presence of preferential protein indicates leukemia
11/13/2001US6316183 Nucleic acid-based methods for the detection of human immunodeficiency virus type 2 (HIV-2)
11/13/2001US6316182 Detection of reverse transcriptase by DNA hybridization assay
11/13/2001US6316181 Expression plasmid for use in the evaluation of tumor cell migration and positioning
11/13/2001US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation
11/13/2001US6315958 Flow cell for synthesis of arrays of DNA probes and the like
11/13/2001US6315955 For analysis of milk and dairy fluids, blood samples, lubricants, suspensions of pigments, for analysis of fat in milk
11/13/2001US6315950 Contacting water with chlorine in the presence of ammonia wherein chloramines are formed, analyzing water after addition of chlorine to determine concentration of monochloramine in water
11/13/2001US6315940 Microelement device
11/13/2001US6315767 Cell storage maintenance and monitoring system
11/13/2001US6315707 Systems and methods for seperating blood in a rotating field
11/13/2001US6314956 Treating lung defects associated hypoxemia or smooth muscle constriction; administer ethyl nitrite to human and monitor
11/13/2001US6314944 Fuel property determination from accumulated intake air amount and accumulated fuel supply amount
11/13/2001US6314806 Automated classing system
11/13/2001US6314805 Yarn quality monitoring
11/13/2001US6314789 Sensor unit for air quality measurement
11/13/2001CA2303505C A monoclonal antibody against estrogen stimulated leucine aminopeptidase
11/12/2001CA2347586A1 Methods of isolating trophoblast cells from maternal blood
11/10/2001CA2347326A1 Polymer libraries on a substrate, method of forming polymer libraries on a substrate and characterization methods with same
11/10/2001CA2347151A1 Method for screening a substance having promoting activity on hair growth
11/10/2001CA2344946A1 Polymer libraries on a substrate, method of forming polymer libraries on a substrate and characterization methods with same
11/08/2001WO2001084463A2 Apparatus, method, and computer program product for quantitative analysis of a nucleic acid amplification reaction
11/08/2001WO2001084459A2 Method for determining significant losses in bone density
11/08/2001WO2001084234A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/08/2001WO2001084197A1 Micro-array evanescent wave fluorescence detection device
11/08/2001WO2001084161A2 Process for the measurement of non-transferrin bound iron
11/08/2001WO2001084160A2 Proteomic determination of protein nitrotyrosine modifications using mass spectrometry
11/08/2001WO2001084159A2 Ldl receptor signaling pathways
11/08/2001WO2001084158A1 Use of the g protein coupled receptor gpr3 to identify appetite control agents
11/08/2001WO2001084157A2 Compositions for detection of multiple analytes
11/08/2001WO2001084156A2 Identification, assessment, prevention, and therapy of human cancers
11/08/2001WO2001084155A1 Methods for identifying novel nucleic acid regulatory elements and compounds that affect the regulation
11/08/2001WO2001084154A1 Method and compositions for drug discovery
11/08/2001WO2001084153A2 Diagnostic device with multiple independent flow paths
11/08/2001WO2001084152A1 Automatic measuring cartridge and mesuring method using it
11/08/2001WO2001084151A1 Chromatography measuring instrument
11/08/2001WO2001084150A1 Biochip for the archiving and medical laboratory analysis of biological sample material
11/08/2001WO2001084149A2 Diagnostics and therapeutics for macular degeneration-related disorders
11/08/2001WO2001084147A1 Method and composition for analyzing a carbohydrate polymer
11/08/2001WO2001084146A2 A sensitive, multiplexed mass-spectrometry-based biosensor based on immuno-pcr
11/08/2001WO2001084145A2 Device for monitoring analytes at sub-micromolar concentrations
11/08/2001WO2001084144A1 Method for in vitro screening of drug candidates useful for the prevention of bone resorption
11/08/2001WO2001084143A1 Proteomic analysis by parallel mass spectrometry
11/08/2001WO2001084142A1 Electrochemical sensing
11/08/2001WO2001084141A1 Assay for acetylcholinesterase inhibitors
11/08/2001WO2001084140A2 Method and device for the qualitative and/or quantitative analysis of a protein and/or peptide pattern of a liquid sample that is derived from the human or animal body
11/08/2001WO2001084138A1 Hematology blood control and method for preparation of same
11/08/2001WO2001084137A1 A quantitative, high-throughput screening method for protein stability
11/08/2001WO2001084136A1 Software nox sensor
11/08/2001WO2001084133A1 Biosensor
11/08/2001WO2001084132A2 Chemosensor and method for calibrating chemosensors
11/08/2001WO2001084112A1 Method and device for collecting and analyzing exhaled breath